CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori (Q45062165)
Jump to navigation
Jump to search
scientific article published in September 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori |
scientific article published in September 2004 |
Statements
1 reference
CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori (English)
1 reference
Matthias Schwab
1 reference
Ulrich Klotz
1 reference
Gerhard Treiber
1 reference
1 September 2004
1 reference
1 reference
76
1 reference
3
1 reference
201-209
1 reference
Identifiers
1 reference
1 reference